The PLCG2 gene helps immune cells pass along signals that guide how your body fights germs and controls inflammation. If it does not work properly, people may have repeated infections, low antibody levels, hives or rashes, or episodes of immune overactivity. Some differences in this gene can change how B cells and other white blood cells respond to triggers.
What is a gene?
Genes are stretches of DNA that provide instructions your cells use to make molecules or regulate activities in the body. Some genes carry the code for proteins, which do much of the work inside cells. Others are used mainly to control when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a closer look at this subject, you can learn more in the LearnHub.
Overview
PLCG2Gene function
What if the gene works
The PLCG2 gene helps immune cells pass signals. Its protein turns membrane fats into small messengers that guide B cells, natural killer cells, and mast cells. These signals help control inflammation and the body’s response to germs.
Risk
What if the gene does not work
Variants in the PLCG2 gene can lead to infections, inflammation, and hives triggered by cold by disrupting immune signaling and antibody production. Effects range from milder to more severe, which can shape when symptoms begin and which features appear.
Treatment
What does that mean for your treatment
No PLCG2-specific treatment or management approach is currently established. In cancer research, acquired variants in the PLCG2 gene are being studied as markers of resistance to BTK inhibitor medicines, which can help explain why some blood cancers stop responding.
Conditions associated with PLCG2
Gene function
What if the gene works
In your body, the PLCG2 gene helps immune cells pass signals from their surface to the inside of the cell. This lets cells react in a measured way when they meet germs or other triggers. Its protein is especially active in B cells and several other white blood cells.
The PLCG2 gene helps carry messages from activated cell surface receptors to the cell's inner control systems. This is a central part of how the PLCG2 gene helps immune cells communicate.
Its protein splits a membrane fat into two small messenger molecules. These messengers quickly pass the signal along inside the cell.
One messenger opens channels that release stored calcium inside the cell. The brief calcium rise helps organize the next steps of cell activity.
In B cells and other white blood cells, this signaling supports activation, movement, and communication. It helps immune cells respond in a controlled way during normal defense.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PLCG2 gene can weaken the protein, make it less stable, or remove a built in brake so cell signaling stays too active. Some changes only partly alter signaling, while more severe variants can sharply reduce activity or trigger signaling at the wrong time. This range in effect helps explain why immune or inflammatory features linked to the PLCG2 gene may be milder in some people and appear earlier or affect more body systems in others.
How variants are linked to conditions
Rare harmful variants in the PLCG2 gene can cause inherited immune system conditions, especially rare syndromes called PLAID and APLAID, which may involve repeated infections, inflammation, skin symptoms, and low or unusual antibody levels. When doctors describe PLCG2 gene variants linked to immune conditions, they mainly mean these syndromes. Separate, more common PLCG2 changes have also been associated with altered risk of late-onset Alzheimer disease, but these risk links do not mean a person will develop dementia.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely found across the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PLCG2, health effects are usually driven mainly by the specific gene change itself rather than by lifestyle or common outside factors. There is not enough evidence to say that diet, exercise, or other routine habits clearly change the chance of developing a PLCG2-related condition, although cold exposure can trigger symptoms in some people with certain PLCG2 changes.
Inheritance of PLCG2 variants
PLCG2-related conditions are usually inherited in an autosomal dominant pattern. That means a parent with a disease-causing variant in the PLCG2 gene can pass it to a child with a 50% chance in each pregnancy, and sons and daughters are affected equally. In some families, PLCG2 gene variant inheritance does not come from either parent because the variant first appears as a new, de novo change in the child.
What does my PLCG2 result mean for my family?
For PLCG2, the main well-established family pattern is dominant, which means close relatives such as a parent, brother, sister, or child may also carry the same gene change. In families with a disease-causing PLCG2 result, relatives can have similar immune or inflammation-related health problems, but the severity can differ a lot from one person to another. Some cases happen for the first time in one family member, so a parent does not always have the same variant.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the PLCG2 gene, genetic testing reads the DNA in a blood or saliva sample. PLCG2 genetic testing may be done on its own, in a multi-gene panel, or through broader sequencing, and the lab checks the gene’s code for changes and reports whether a variant was found.
When should I consider getting a genetic test?
Consider PLCG2 genetic testing if there is a pattern of repeated infections, cold-triggered hives or rashes, ongoing inflammation, or low antibody levels, especially when similar problems run in the family. Testing can help clarify whether a PLCG2-related immune condition is the cause.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and on the specific type of variant. Over time, the way the body works is also shaped by influences such as lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, it can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Small inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it at its target. These differences are common and can influence both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment may work differently from one person to another. With many medicines, genes affect how strongly a drug works or how the body handles it. This information can support better informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the PLCG2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication decisions, so general health or medicine questions are best discussed with your doctor. In cancer care, PLCG2 changes in tumor cells have been linked to resistance to some targeted treatments for certain blood cancers, so people already being treated for one of these cancers can ask their cancer team whether this matters for their care.
History
PLCG2 entered medical genetics through research on cell signaling in the late 20th century, when scientists were mapping genes that help immune cells respond to outside cues. In recent decades, awareness of this gene’s role has grown as inherited PLCG2 variants were linked to rare conditions involving inflammation, antibody problems, and cold triggered symptoms. These findings helped connect older clinical descriptions with a clear genetic cause. Researchers later identified acquired PLCG2 variants in some blood cancers, especially in people whose disease changed during treatment. Interest in the PLCG2 gene expanded again when a particular variant was linked to altered risk of late onset Alzheimer disease. Together, these discoveries moved PLCG2 from a laboratory finding to a gene with recognized importance in immunology, cancer research, and brain aging.